NEWSROOM

Kurma Partners announces the first closing of 
Kurma Biofund III

14 / 12 / 2018Press release

Servier joins Embleema’s Blockchain Health Consortium to launch a pilot project for Blockchain

04 / 12 / 2018Press release

Servier and Allogene Therapeutics present pooled data from Phase 1 Trials of Allogeneic UCART19 in Relapsed/Refractory Acute Lymphoblastic Leukemia

04 / 12 / 2018Press release

Mécénat Servier celebrates its second anniversary

28 / 11 / 2018Press release

WeHealth by Servier and MobioSense form a partnership to develop digital portable heart attack detection test

26 / 11 / 2018Press release

Servier lays the foundation stone of the future bioproduction unit on the Gidy industrial site

15 / 11 / 2018Press release

Servier backs an American startup at LabCentral in the field of mitochondrial health for neurodegenerative and rare diseases

14 / 11 / 2018Press release

Servier and Allogene Therapeutics Announce Data Presentations of UCART19 First-in-Human Trials at 60th American Society of Hematology (ASH) Annual Meeting

12 / 11 / 2018Press release

Servier joins Patient-Focused Medicines Development (PFMD) Collective Platform

25 / 10 / 2018Press release

Servier, in the top 5 companies favoured by students and young graduates

18 / 10 / 2018Press release

Professor Michel Sadelain wins the 2018 Pasteur-Weizmann/Servier Prize for his work on immunoregulation and cancer

16 / 10 / 2018Press release

10th anniversary of our Research Institute of Medicinal Chemistry in Hungary

10 / 10 / 2018Press release